Knaul Felicia Marie, Arreola-Ornelas Héctor, Velázquez Enrique, Dorantes Javier, Méndez Oscar, Avila-Burgos Leticia
Tómatelo a Pecho y Observatorio de la Salud, Instituto Carso de la Salud, Fundación Mexicana para la Salud, México, DF.
Salud Publica Mex. 2009;51 Suppl 2:s286-95. doi: 10.1590/s0036-36342009000800019.
We studied the cost of health care for women with breast cancer treated at the Mexican Social Security Institute (IMSS, per its abbreviation in Spanish).
Using the Medical and Operative Information Systems of the IMSS, we constructed a cohort of patients diagnosed in 2002 and followed these patients to the end of 2006, identifying the use of resources and imputing the IMSS-specific cost structure.
Only 14% of women were diagnosed in stage 1 and 48% were diagnosed in stages III-IV. The average cost of their medical care per patient-year was $MX110,459. Costs for stage 1 were $MX74,522 compared to $102,042 for stage II, and were $MX154,018 for stage III and $MX199,274 for stage IV.
Breast cancer accounts for a significant part of the IMSS health budget. Later stage at diagnosis is associated with higher economic costs per patient-year of treatment and lower probability of five-year survival.
我们研究了在墨西哥社会保障局(IMSS,西班牙语缩写)接受治疗的乳腺癌女性的医疗费用。
利用IMSS的医疗和手术信息系统,我们构建了一个2002年被诊断出的患者队列,并对这些患者进行随访直至2006年底,确定资源使用情况并估算IMSS特定的成本结构。
仅14%的女性在I期被诊断出,48%在III-IV期被诊断出。每位患者每年的医疗平均费用为110,459墨西哥比索。I期的费用为74,522墨西哥比索,II期为102,042墨西哥比索,III期为154,018墨西哥比索,IV期为199,274墨西哥比索。
乳腺癌在IMSS医疗预算中占很大一部分。诊断时较晚的阶段与每位患者每年治疗的较高经济成本以及较低的五年生存率相关。